How have CVSI shares performed in 2024?

CV Sciences' stock was trading at $0.0354 at the beginning of the year. Since then, CVSI stock has increased by 13.0% and is now trading at $0.04. View the best growth stocks for 2024 here .

Are investors shorting CV Sciences?

CV Sciences saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 27,600 shares, an increase of 305.9% from the March 15th total of 6,800 shares. Based on an average trading volume of 818,700 shares, the days-to-cover ratio is presently 0.0 days. View CV Sciences' Short Interest .

How were CV Sciences' earnings last quarter?

CV Sciences, Inc. (OTCMKTS:CVSI) issued its quarterly earnings data on Thursday, March, 28th. The company reported ($0.01) EPS for the quarter. The company earned $3.80 million during the quarter. CV Sciences had a trailing twelve-month return on equity of 80.98% and a net margin of 19.38%.

What other stocks do shareholders of CV Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CV Sciences investors own include Cronos Group (CRON) , Charlotte's Web (CWBHF) , KushCo (KSHB) , Organigram (OGI) , GW Pharmaceuticals (GWPH) , Tilray (TLRY) and Medical Marijuana (MJNA) .

How do I buy shares of CV Sciences?

Shares of CVSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:CVSI

CV Sciences (CVSI) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free CVSI Stock Alerts

$0.04

0.00 (0.00%)

(As of 04/18/2024 ET)

Compare

Today's Range: $0.03
▼
$0.04
50-Day Range: $0.03
▼
$0.04
52-Week Range: $0.03
▼
$0.06

Volume: 274,474 shs
Average Volume: 232,761 shs
Market Capitalization: $6.53 million

P/E Ratio: 2.00
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Earnings Financials Headlines SEC Filings Short Interest

Get CV Sciences alerts:

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About CV Sciences Stock (OTCMKTS:CVSI)

CV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers. It is also developing cannabinoids intended to treat medical indications, including CVSI-007 that combines CBD and nicotine for the treatment of smokeless tobacco use and addiction. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.

CVSI Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CVSI Stock News Headlines

April 1, 2024 | finance.yahoo.com

CV Sciences, Inc. (PNK:CVSI) Q4 2023 Earnings Call Transcript

March 28, 2024 | investorplace.com

CVSI Stock Earnings: CV Sciences Reported Results for Q4 2023

April 19, 2024 | InvestorPlace (Ad)

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

March 28, 2024 | prnewswire.com

CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results

March 27, 2024 | wsj.com

CV Sciences Inc.

March 26, 2024 | finance.yahoo.com

CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews

March 21, 2024 | prnewswire.com

CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2023 RESULTS ON MARCH 28, 2024

February 22, 2024 | benzinga.com

CV Sciences Stock (OTC:CVSI), Short Interest Report

April 19, 2024 | InvestorPlace (Ad)

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

December 12, 2023 | finance.yahoo.com

CV Sciences, Inc. Acquires Cultured Foods To Enter Plant-Based Food Market, Opening Door For European Distribution

November 15, 2023 | nz.finance.yahoo.com

The Best Shampoo for Thinning Hair We Tested Is 30% Off Right Now

November 15, 2023 | finance.yahoo.com

CV Sciences, Inc. (PNK:CVSI) Q3 2023 Earnings Call Transcript

November 14, 2023 | benzinga.com

Hemp-Focused Wellness Company: Revenue Jumps To $4.1M, Gross Margin Peaks At 45.1%

November 14, 2023 | msn.com

CV Sciences GAAP EPS of $0.00, revenue of $4.09M

November 14, 2023 | finance.yahoo.com

CV Sciences, Inc. Reports Third Quarter 2023 Financial Results

November 12, 2023 | morningstar.com

CV Sciences Inc CVSI

November 9, 2023 | finance.yahoo.com

CV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2023 RESULTS ON NOVEMBER 14, 2023

September 5, 2023 | finance.yahoo.com

CV Sciences, Inc. Launches Reserve Sleep Gummies

August 15, 2023 | finance.yahoo.com

CV Sciences, Inc. (PNK:CVSI) Q2 2023 Earnings Call Transcript

August 14, 2023 | seekingalpha.com

CV Sciences GAAP EPS of -$0.01, revenue of $4M

August 14, 2023 | benzinga.com

Publicly Traded Hemp-Focused Wellness Company Reports Q2 Results, Here Is What You Need To Know

August 14, 2023 | finance.yahoo.com

CV Sciences, Inc. Reports Second Quarter 2023 Financial Results

August 1, 2023 | finance.yahoo.com

CV SCIENCES, INC. TO ANNOUNCE SECOND QUARTER 2023 RESULTS ON AUGUST 14, 2023

July 8, 2023 | finance.yahoo.com

CVSI - CV Sciences, Inc.

June 1, 2023 | finance.yahoo.com

CV Sciences to Participate in LD Micro Invitational Conference

May 15, 2023 | msn.com

CV Sciences Inc Q1 Revenue Stagnates YoY, Here Is What You Need To Know

May 15, 2023 | finance.yahoo.com

CV Sciences, Inc. Reports First Quarter 2023 Financial Results

See More Headlines

Receive CVSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CV Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/28/2024
Today: 4/18/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: OTCMKTS:CVSI
Previous Symbol: NASDAQ:CVSI
CUSIP: N/A
CIK: 1510964
Web: www.cvsciences.com
Phone: (866) 290-2157
Fax: 619-876-4321
Employees: 42
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): $0.02
Trailing P/E Ratio: 2.00
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $3.10 million
Net Margins: 19.38%
Pretax Margin: 19.34%
Return on Equity: 80.98%
Return on Assets: 30.87%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.30
Quick Ratio: 0.37

Sales & Book Value

Annual Sales: $16 million
Price / Sales: 0.41
Cash Flow: $0.02 per share
Price / Cash Flow: 1.80
Book Value: $0.02 per share
Price / Book: 2.00

Miscellaneous

Outstanding Shares: 163,230,000
Free Float: 163,032,000
Market Cap: $6.53 million
Optionable: Not Optionable
Beta: 0.62

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Mr. Joseph D. Dowling (Age 67)
CEO, Secretary & Director
Comp: $298.98k
Mr. Joerg Grasser (Age 49)
Chief Financial Officer
Comp: $210.47k
Mr. Tim Hitchman
Vice President of Operations
Mr. Jesse Karagianes
Senior Vice President of Revenue Growth
Ms. Alyssa Dunn
Operations Manager

Key Competitors

View All Competitors

CVSI Stock Analysis - Frequently Asked Questions

How have CVSI shares performed in 2024?: CV Sciences' stock was trading at $0.0354 at the beginning of the year. Since then, CVSI stock has increased by 13.0% and is now trading at $0.04.
View the best growth stocks for 2024 here.
Are investors shorting CV Sciences?: CV Sciences saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 27,600 shares, an increase of 305.9% from the March 15th total of 6,800 shares. Based on an average trading volume of 818,700 shares, the days-to-cover ratio is presently 0.0 days.
View CV Sciences' Short Interest.
How were CV Sciences' earnings last quarter?: CV Sciences, Inc. (OTCMKTS:CVSI) issued its quarterly earnings data on Thursday, March, 28th. The company reported ($0.01) EPS for the quarter. The company earned $3.80 million during the quarter. CV Sciences had a trailing twelve-month return on equity of 80.98% and a net margin of 19.38%.

What other stocks do shareholders of CV Sciences own?: Based on aggregate information from My MarketBeat watchlists, some companies that other CV Sciences investors own include Cronos Group (CRON), Charlotte's Web (CWBHF), KushCo (KSHB), Organigram (OGI), GW Pharmaceuticals (GWPH), Tilray (TLRY) and Medical Marijuana (MJNA).
How do I buy shares of CV Sciences?: Shares of CVSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CVSI) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

CV Sciences (CVSI) Stock Price, News & Analysis

About CV Sciences Stock (OTCMKTS:CVSI)

CVSI Stock Price History

CVSI Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

CVSI Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info